These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36319022)

  • 41. Effects of cyclosporin on joint damage in rheumatoid arthritis. The Italian Rheumatologists Study Group on Rheumatoid Arthritis.
    Ferraccioli GF; Bambara LM; Ferraris M; Perpignano G; Cattaneo R; Porzio F; Accardo S; Mattara L; Zoppini A; Benucci M; Ostuni PA; Pasero G
    Clin Exp Rheumatol; 1997; 15 Suppl 17():S83-9. PubMed ID: 9266138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics Trials.
    Boers M; Aletaha D; Mela CM; Baker DG; Smolen JS
    J Rheumatol; 2016 Jun; 43(6):1024-6. PubMed ID: 27036379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis.
    van der Heide A; Remme CA; Hofman DM; Jacobs JW; Bijlsma JW
    Arthritis Rheum; 1995 Oct; 38(10):1466-74. PubMed ID: 7575696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice.
    Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1247-53. PubMed ID: 21671420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE).
    Smolen JS; Wollenhaupt J; Gomez-Reino JJ; Grassi W; Gaillez C; Poncet C; Le Bars M; Westhovens R
    Arthritis Res Ther; 2015 Jun; 17(1):157. PubMed ID: 26063454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial.
    Tavares R; Beattie KA; Bensen WG; Bobba RS; Cividino AA; Finlay K; Goeree R; Hart LE; Jurriaans E; Larche MJ; Parasu N; Tarride JE; Webber CE; Adachi JD
    Trials; 2014 Jul; 15():268. PubMed ID: 24997587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model.
    Helliwell PS; Hetthen J; Sokoll K; Green M; Marchesoni A; Lubrano E; Veale D; Emery P
    Arthritis Rheum; 2000 Apr; 43(4):865-71. PubMed ID: 10765932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis.
    Landewé R; Smolen JS; Florentinus S; Chen S; Guérette B; van der Heijde D
    Arthritis Res Ther; 2015 May; 17(1):133. PubMed ID: 25994819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome.
    van Tuyl LH; Britsemmer K; Wells GA; Smolen JS; Zhang B; Funovits J; van Schaardenburg D; Felson D; Boers M
    Ann Rheum Dis; 2012 Jan; 71(1):33-7. PubMed ID: 21953347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early and aggressive treatment affects the association of HLA-DRB1 genes with progression of joint damage: comment on the article by Lard et al.
    Rau R; Herborn G; Fenner H
    Arthritis Rheum; 2003 Feb; 48(2):579. PubMed ID: 12571873
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.
    Niki Y; Takeuchi T; Nakayama M; Nagasawa H; Kurasawa T; Yamada H; Toyama Y; Miyamoto T
    PLoS One; 2012; 7(5):e37447. PubMed ID: 22629396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
    Bathon JM; Martin RW; Fleischmann RM; Tesser JR; Schiff MH; Keystone EC; Genovese MC; Wasko MC; Moreland LW; Weaver AL; Markenson J; Finck BK
    N Engl J Med; 2000 Nov; 343(22):1586-93. PubMed ID: 11096165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients.
    Katayama K; Matsuno T
    Mod Rheumatol; 2009; 19(5):513-21. PubMed ID: 19603251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study.
    Markusse IM; Dirven L; van den Broek M; Bijkerk C; Han KH; Ronday HK; Bolce R; Sasso EH; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF
    J Rheumatol; 2014 Nov; 41(11):2114-9. PubMed ID: 25128518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of a high-intensity weight-bearing exercise program on radiologic damage progression of the large joints in subgroups of patients with rheumatoid arthritis.
    Munneke M; de Jong Z; Zwinderman AH; Ronday HK; van Schaardenburg D; Dijkmans BA; Kroon HM; Vliet Vlieland TP; Hazes JM
    Arthritis Rheum; 2005 Jun; 53(3):410-7. PubMed ID: 15934121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of Distinct Disease Activity Trajectories in Methotrexate-Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty-Four Months.
    Bykerk VP; Lee EB; van Vollenhoven R; Gruben DC; Fallon L; Woolcott JC; Keystone E
    Arthritis Care Res (Hoboken); 2022 Jan; 74(1):131-141. PubMed ID: 34057820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint.
    Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T
    Rheumatology (Oxford); 2013 Mar; 52(3):523-8. PubMed ID: 23192908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low Hemoglobin and Radiographic Damage Progression in Early Rheumatoid Arthritis: Secondary Analysis From a Phase III Trial.
    Möller B; Everts-Graber J; Florentinus S; Li Y; Kupper H; Finckh A
    Arthritis Care Res (Hoboken); 2018 Jun; 70(6):861-868. PubMed ID: 28950430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tightening up? Impact of musculoskeletal ultrasound disease activity assessment on early rheumatoid arthritis patients treated using a treat to target strategy.
    Dale J; Purves D; McConnachie A; McInnes I; Porter D
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):19-26. PubMed ID: 24376248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.